Literature DB >> 24690908

Mangromicins, six new anti-oxidative agents isolated from a culture broth of the actinomycete, Lechevalieria aerocolonigenes K10-0216.

Takuji Nakashima1, Yoshiyuki Kamiya2, Masato Iwatsuki3, Yōko Takahashi3, Satoshi Ōmura4.   

Abstract

We have been continually searching for novel chemical compounds from culture broths of various actinomycetes using a physicochemical screening system. During the course of this program, we have previously reported the discovery of two new natural products, designated mangromicins A and B, discovered in a broth of a rare actinomycete strain, Lechevalieria aerocolonigenes K10-0216. Mangromicins have a unique and rare structure, a cyclopentadecane skeleton with a tetrahydrofuran unit and a 5,6-dihydro-4-hydroxy-2-pyrone moiety. New mangromicin analogs were isolated by using an improved production medium. As a consequence, six analogs, together with mangromicins A and B, were isolated from a cultured broth of L. aerocolonigenes K10-0216. We named them mangromicins D, E, F, G, H and I. All mangromicins showed radical scavenging activities against 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radicals and nitric oxide generated from LPS-stimulated RAW264.7 cells, a murine macrophage cell line. Among the analogs, mangromicins A and I showed the most potent DPPH radical scavenging activity and nitric oxide scavenging activity, respectively.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24690908     DOI: 10.1038/ja.2014.34

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  9 in total

1.  New steroidal compounds from an actinomycete strain, Lechevalieria aerocolonigenes K10-0216.

Authors:  Takuji Nakashima; Yoshiyuki Kamiya; Kenzaburo Yamaji; Masato Iwatsuki; Noriko Sato; Yōko Takahashi; Satoshi Ōmura
Journal:  J Antibiot (Tokyo)       Date:  2014-12-10       Impact factor: 2.649

2.  Iminimycin A, the new iminium metabolite produced by Streptomyces griseus OS-3601.

Authors:  Takuji Nakashima; Rei Miyano; Masato Iwatsuki; Tatsuya Shirahata; Toru Kimura; Yukihiro Asami; Yoshinori Kobayashi; Kazuro Shiomi; George A Petersson; Yōko Takahashi; Satoshi Ōmura
Journal:  J Antibiot (Tokyo)       Date:  2016-01-13       Impact factor: 2.649

3.  Mangromicin C, a new analog of mangromicin.

Authors:  Takuji Nakashima; Yoshiyuki Kamiya; Masato Iwatsuki; Noriko Sato; Yōko Takahashi; Satoshi Ōmura
Journal:  J Antibiot (Tokyo)       Date:  2014-10-01       Impact factor: 2.649

4.  Anti-trypanosomal compound, sagamilactam, a new polyene macrocyclic lactam from Actinomadura sp. K13-0306.

Authors:  Tōru Kimura; Masato Iwatsuki; Yukihiro Asami; Aki Ishiyama; Rei Hokari; Kazuhiko Otoguro; Atsuko Matsumoto; Noriko Sato; Kazuro Shiomi; Yōko Takahashi; Satoshi Ōmura; Takuji Nakashima
Journal:  J Antibiot (Tokyo)       Date:  2016-03-30       Impact factor: 2.649

Review 5.  The secondary metabolites of rare actinomycetes: chemistry and bioactivity.

Authors:  Ting Ding; Luo-Jie Yang; Wei-Dong Zhang; Yun-Heng Shen
Journal:  RSC Adv       Date:  2019-07-16       Impact factor: 4.036

Review 6.  Actinomycetes, an Inexhaustible Source of Naturally Occurring Antibiotics.

Authors:  Yōko Takahashi; Takuji Nakashima
Journal:  Antibiotics (Basel)       Date:  2018-05-24

Review 7.  Natural Polypropionates in 1999-2020: An Overview of Chemical and Biological Diversity.

Authors:  Zhaoming Liu; Hongxin Liu; Weimin Zhang
Journal:  Mar Drugs       Date:  2020-11-19       Impact factor: 5.118

Review 8.  The Tetrahydrofuran Motif in Polyketide Marine Drugs.

Authors:  Laura Fernández-Peña; Carlos Díez-Poza; Paula González-Andrés; Asunción Barbero
Journal:  Mar Drugs       Date:  2022-02-03       Impact factor: 5.118

9.  Colonization and Interaction of Bacteria Associated With Chinese Chives Affected by Ecological Compartments and Growth Conditions.

Authors:  Nan Sun; Yuxin Wang; Jianhua Chen; Pingzhi Wang; Weitang Song; Peifang Ma; Yabin Duan; Ziyuan Jiao; Yixiao Li
Journal:  Front Microbiol       Date:  2022-02-14       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.